GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation

Scientists review the clinical manifestations of GATA2 deficiency, characterization of the hematologic abnormalities and progression to myeloid malignancy, and current hematopoietic cell transplantation practices and outcomes.